Sophia Wakefield | Medicine and Health Sciences | Women Researcher Award

Dr. Sophia Wakefield | Medicine and Health Sciences | Women Researcher Award

Doctor University of Leeds United Kingdom

đź“š Dr. Sophia Wakefield, born in 1999, is a passionate and accomplished medical professional specializing in Trauma and Orthopaedics. Currently employed as a Hospital Doctor with Health Education Yorkshire and Humber, she is committed to advancing clinical practice, research, and education in her field.

Profile

Scopus

Education

🎓 Postgraduate Education

  • Master of Research in Medicine (Distinction) – September 2023 to September 2024
  • Postgraduate Certificate in Medical Education (Distinction) – September 2023 to June 2024

🎓 Undergraduate Education

  • MBBCh – September 2017 to July 2023
  • BSc in Clinical Sports Science (First Class Honours) – September 2021 to June 2022

Experience

đź’Ľ Dr. Wakefield is currently a Hospital Doctor at Health Education Yorkshire and Humber. Her extensive clinical training includes experiences in Trauma and Orthopaedics and medical education. She actively participates in research projects and leadership roles in national organizations.

Research Interests

🔬 Dr. Wakefield’s research focuses on:

  • Trauma and Orthopaedics
  • Rehabilitation techniques
  • Medical education innovation
  • Fracture management and surgical techniques

Awards and Achievements

🏆 Prizes and Awards

  • Second place, Oral Presentation at RCSEd Foundation Trainees Surgical Society National Conference (2024)
  • Postgraduate ÂŁ6k funding grant awarded by Leeds Hospitals Charity (2024)

👩‍🔬 National Leadership Roles

  • Social Media Lead for British Orthopaedic Medical Students Association (2022–2023)
  • Student Ambassador for Students for Research Network (2022–current)

Publications Top Notes: 

đź“– Peer-Reviewed Articles

Wakefield, S.M., Kanakaris, N.K., & Giannoudis, P.V. (2025). Sexual and Urinary Dysfunction Following Isolated Acetabulum Fractures: A Systematic Review of the Literature. J Clin Med, 1(230). Read Here

Cited by: 12 articles

Watson, P., Hanna, D., Wakefield, S. M., et al. (2024). Undergraduate rheumatology teaching in the UK: A survey of current practice by teachers and students. Rheumatology Advances in Practice, 8(4). Read Here

Cited by: 8 articles

Wakefield, S. M., Rodham, P. L., & Giannoudis, P. V. (2024). The management of intertrochanteric hip fractures: An update. Orthopaedics and Trauma, 38(2), 70–77. Read Here

Cited by: 15 articles

Wakefield, S. M., et al. (2024). Distraction osteogenesis versus induced membrane technique for infected tibial non-unions. European Journal of Trauma and Emergency Surgery, 50(3), 705–721. Read Here

Cited by: 20 articles

Stefano Stefano | Medicine and Health Sciences | Best Researcher Award

Dr. Stefano Stefano | Medicine and Health Sciences | Best Researcher Award

MD, Specializing in Rheumatology (4th year) University of Bari, Rheumatology Unit Italy

👨‍⚕️ Stefano Stano is a 4th-year MD specializing in Rheumatology at the University of Bari “Aldo Moro,” Polyclinic Hospital. His passion for rheumatology and medical research drives his active involvement in clinical and translational studies, focusing on systemic sclerosis, Sjögren’s disease, and other connective tissue disorders. Stefano aspires to pursue a Ph.D. and build an academic career contributing to advancements in rheumatology.

Profile

Orcid

Education

🎓 Stefano holds an MD and is in the final year of his specialization in Rheumatology at the University of Bari “Aldo Moro.” His academic journey is marked by consistent dedication to both theoretical and practical aspects of his field.

Experience

đź©ş With over 5 years of daily involvement in research and clinical practice, Stefano balances laboratory experiments and outpatient assessments. His hands-on approach to rheumatic diseases has honed his skills in addressing complex cases and conducting in-depth studies.

Research Interests

🔬 Stefano’s research is centered on rheumatic diseases, with a special emphasis on systemic sclerosis and Sjögren’s syndrome. He is particularly interested in exploring translational approaches that bridge laboratory findings with clinical applications.

Awards

🏅 Stefano aims to secure the Best Researcher Award in recognition of his efforts in advancing rheumatological research. His dedication and achievements position him as a strong contender.

Publications Top Notes: 

📚 Stefano’s contributions to the field are evidenced by his peer-reviewed publications, which include studies on targeted therapies, systemic sclerosis, and rheumatoid arthritis. His works have been published in reputed journals:

Cacciapaglia F, et al. (2022). Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis. J Pers Med. Read here.

Fornaro M, et al. (2022). Prevalence and management of tuberculosis infection in Apulian rheumatologic patients treated with biologics: An observational cohort 10-year study from the BIOPURE registry. Eur J Clin Invest. Read here.

Cacciapaglia F, et al. (2022). Subcutaneous immunoglobulin therapy for refractory skin thickening in rapidly progressive systemic sclerosis: A case report and literature review. Journal of Scleroderma and Related Disorders. Read here.

De Luca G, et al. (2024). Rituximab retention rate in systemic sclerosis: a long-term real-life multicenter study. Rheumatology. Read here.

Iannone C, et al. (2024). Pulmonary and extra-pulmonary effects of lung transplantation in systemic sclerosis. Rheumatology. Read here.

De Lorenzis E, et al. (2024). Long-term retention rate, adverse event temporal patterns, and rescue treatment strategies of mycophenolate mofetil in systemic sclerosis: insights from real-life. Rheumatology. Read here.

Fornaro M, et al. (2024). Effectiveness of tapering rituximab dose in idiopathic inflammatory myopathies: Real-world data from a monocentric study. Joint Bone Spine. Read here.

Stano S, et al. (2024). Anti-aquaporin-5 and anti-poly-U-binding-factor-60kDa protein antibodies in primary Sjögren’s disease patients: Preliminary data and correlation with disease activity indices. Clin Exp Rheumatol. Read here.

Cacciapaglia F, et al. (2024). Modulation of IL-6 receptor/STAT3 downstream signaling in rheumatoid arthritis patients. Exp Mol Pathol. Read here.